U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
XELIGEKIMAB
INN  
Official Name English
xeligekimab [INN]
Common Name English
GR-1501
Common Name English
GR1501
Common Name English
IMMUNOGLOBULIN G4 (235-PROLINE), ANTI-(HUMAN INTERLEUKIN 17A) (HUMAN MONOCLONAL GR1501 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL GR1501 .KAPPA.-CHAIN, DIMER
Common Name English
Code System Code Type Description
NCI_THESAURUS
C188599
Created by admin on Sat Dec 16 18:52:45 GMT 2023 , Edited by admin on Sat Dec 16 18:52:45 GMT 2023
PRIMARY
INN
11625
Created by admin on Sat Dec 16 18:52:45 GMT 2023 , Edited by admin on Sat Dec 16 18:52:45 GMT 2023
PRIMARY
FDA UNII
MC5WXU879E
Created by admin on Sat Dec 16 18:52:45 GMT 2023 , Edited by admin on Sat Dec 16 18:52:45 GMT 2023
PRIMARY
CAS
2382921-73-3
Created by admin on Sat Dec 16 18:52:45 GMT 2023 , Edited by admin on Sat Dec 16 18:52:45 GMT 2023
PRIMARY
ACTIVE MOIETY
XELIGEKIMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966